Copyright Reports & Markets. All rights reserved.

Global Disease Risk and Health Genetic Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Disease Risk and Health Genetic Test Market Overview

    • 1.1 Product Overview and Scope of Disease Risk and Health Genetic Test
    • 1.2 Classification of Disease Risk and Health Genetic Test by Types
      • 1.2.1 Global Disease Risk and Health Genetic Test Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Disease Risk and Health Genetic Test Revenue Market Share by Types in 2018
      • 1.2.3 Celiac Disease
      • 1.2.4 Parkinson Disease
      • 1.2.5 Alzheimer Disease
      • 1.2.6 Other
    • 1.3 Global Disease Risk and Health Genetic Test Market by Application
      • 1.3.1 Global Disease Risk and Health Genetic Test Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Online
      • 1.3.3 Offline
    • 1.4 Global Disease Risk and Health Genetic Test Market by Regions
      • 1.4.1 Global Disease Risk and Health Genetic Test Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Disease Risk and Health Genetic Test Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Disease Risk and Health Genetic Test Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Disease Risk and Health Genetic Test Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Disease Risk and Health Genetic Test Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Disease Risk and Health Genetic Test Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Disease Risk and Health Genetic Test (2014-2024)

    2 Manufacturers Profiles

    • 2.1 23andMe
      • 2.1.1 Business Overview
      • 2.1.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 23andMe Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 MyHeritage
      • 2.2.1 Business Overview
      • 2.2.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 MyHeritage Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 LabCorp
      • 2.3.1 Business Overview
      • 2.3.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 LabCorp Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Myriad Genetics
      • 2.4.1 Business Overview
      • 2.4.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Myriad Genetics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Ancestry.com
      • 2.5.1 Business Overview
      • 2.5.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Ancestry.com Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Quest Diagnostics
      • 2.6.1 Business Overview
      • 2.6.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Quest Diagnostics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Gene By Gene
      • 2.7.1 Business Overview
      • 2.7.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Gene By Gene Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 DNA Diagnostics Center
      • 2.8.1 Business Overview
      • 2.8.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 DNA Diagnostics Center Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Invitae
      • 2.9.1 Business Overview
      • 2.9.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Invitae Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 IntelliGenetics
      • 2.10.1 Business Overview
      • 2.10.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 IntelliGenetics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Ambry Genetics
      • 2.11.1 Business Overview
      • 2.11.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Ambry Genetics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Living DNA
      • 2.12.1 Business Overview
      • 2.12.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Living DNA Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 EasyDNA
      • 2.13.1 Business Overview
      • 2.13.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 EasyDNA Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Pathway Genomics
      • 2.14.1 Business Overview
      • 2.14.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Pathway Genomics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Centrillion Technology
      • 2.15.1 Business Overview
      • 2.15.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Centrillion Technology Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Xcode
      • 2.16.1 Business Overview
      • 2.16.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Xcode Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Color Genomics
      • 2.17.1 Business Overview
      • 2.17.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Color Genomics Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Anglia DNA Services
      • 2.18.1 Business Overview
      • 2.18.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Anglia DNA Services Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 African Ancestry
      • 2.19.1 Business Overview
      • 2.19.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 African Ancestry Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Canadian DNA Services
      • 2.20.1 Business Overview
      • 2.20.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Canadian DNA Services Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 DNA Family Check
      • 2.21.1 Business Overview
      • 2.2.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 DNA Family Check Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Alpha Biolaboratories
      • 2.22.1 Business Overview
      • 2.22.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Alpha Biolaboratories Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.23 Test Me DNA
      • 2.23.1 Business Overview
      • 2.23.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.23.2.1 Product A
        • 2.23.2.2 Product B
      • 2.23.3 Test Me DNA Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.24 23 Mofang
      • 2.24.1 Business Overview
      • 2.24.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.24.2.1 Product A
        • 2.24.2.2 Product B
      • 2.24.3 23 Mofang Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.25 Genetic Health
      • 2.25.1 Business Overview
      • 2.25.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.25.2.1 Product A
        • 2.25.2.2 Product B
      • 2.25.3 Genetic Health Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.26 DNA Services of America
      • 2.26.1 Business Overview
      • 2.26.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.26.2.1 Product A
        • 2.26.2.2 Product B
      • 2.26.3 DNA Services of America Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.27 Shuwen Health Sciences
      • 2.27.1 Business Overview
      • 2.27.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.27.2.1 Product A
        • 2.27.2.2 Product B
      • 2.27.3 Shuwen Health Sciences Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.28 Mapmygenome
      • 2.28.1 Business Overview
      • 2.28.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.28.2.1 Product A
        • 2.28.2.2 Product B
      • 2.28.3 Mapmygenome Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)
    • 2.29 Full Genomes
      • 2.29.1 Business Overview
      • 2.29.2 Disease Risk and Health Genetic Test Type and Applications
        • 2.29.2.1 Product A
        • 2.29.2.2 Product B
      • 2.29.3 Full Genomes Disease Risk and Health Genetic Test Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Disease Risk and Health Genetic Test Market Competition, by Players

    • 3.1 Global Disease Risk and Health Genetic Test Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Disease Risk and Health Genetic Test Players Market Share
      • 3.2.2 Top 10 Disease Risk and Health Genetic Test Players Market Share
    • 3.3 Market Competition Trend

    4 Global Disease Risk and Health Genetic Test Market Size by Regions

    • 4.1 Global Disease Risk and Health Genetic Test Revenue and Market Share by Regions
    • 4.2 North America Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 4.5 South America Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    5 North America Disease Risk and Health Genetic Test Revenue by Countries

    • 5.1 North America Disease Risk and Health Genetic Test Revenue by Countries (2014-2019)
    • 5.2 USA Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    6 Europe Disease Risk and Health Genetic Test Revenue by Countries

    • 6.1 Europe Disease Risk and Health Genetic Test Revenue by Countries (2014-2019)
    • 6.2 Germany Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 6.3 UK Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 6.4 France Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Disease Risk and Health Genetic Test Revenue by Countries

    • 7.1 Asia-Pacific Disease Risk and Health Genetic Test Revenue by Countries (2014-2019)
    • 7.2 China Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 7.5 India Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    8 South America Disease Risk and Health Genetic Test Revenue by Countries

    • 8.1 South America Disease Risk and Health Genetic Test Revenue by Countries (2014-2019)
    • 8.2 Brazil Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Disease Risk and Health Genetic Test by Countries

    • 9.1 Middle East and Africa Disease Risk and Health Genetic Test Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Disease Risk and Health Genetic Test Revenue and Growth Rate (2014-2019)

    10 Global Disease Risk and Health Genetic Test Market Segment by Type

    • 10.1 Global Disease Risk and Health Genetic Test Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Disease Risk and Health Genetic Test Market Forecast by Type (2019-2024)
    • 10.3 Celiac Disease Revenue Growth Rate (2014-2024)
    • 10.4 Parkinson Disease Revenue Growth Rate (2014-2024)
    • 10.5 Alzheimer Disease Revenue Growth Rate (2014-2024)
    • 10.6 Other Revenue Growth Rate (2014-2024)

    11 Global Disease Risk and Health Genetic Test Market Segment by Application

    • 11.1 Global Disease Risk and Health Genetic Test Revenue Market Share by Application (2014-2019)
    • 11.2 Disease Risk and Health Genetic Test Market Forecast by Application (2019-2024)
    • 11.3 Online Revenue Growth (2014-2019)
    • 11.4 Offline Revenue Growth (2014-2019)

    12 Global Disease Risk and Health Genetic Test Market Size Forecast (2019-2024)

    • 12.1 Global Disease Risk and Health Genetic Test Market Size Forecast (2019-2024)
    • 12.2 Global Disease Risk and Health Genetic Test Market Forecast by Regions (2019-2024)
    • 12.3 North America Disease Risk and Health Genetic Test Revenue Market Forecast (2019-2024)
    • 12.4 Europe Disease Risk and Health Genetic Test Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Disease Risk and Health Genetic Test Revenue Market Forecast (2019-2024)
    • 12.6 South America Disease Risk and Health Genetic Test Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Disease Risk and Health Genetic Test Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

      Scope of the Report:
      The global Disease Risk and Health Genetic Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Disease Risk and Health Genetic Test.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Disease Risk and Health Genetic Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Disease Risk and Health Genetic Test market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      23andMe
      MyHeritage
      LabCorp
      Myriad Genetics
      Ancestry.com
      Quest Diagnostics
      Gene By Gene
      DNA Diagnostics Center
      Invitae
      IntelliGenetics
      Ambry Genetics
      Living DNA
      EasyDNA
      Pathway Genomics
      Centrillion Technology
      Xcode
      Color Genomics
      Anglia DNA Services
      African Ancestry
      Canadian DNA Services
      DNA Family Check
      Alpha Biolaboratories
      Test Me DNA
      23 Mofang
      Genetic Health
      DNA Services of America
      Shuwen Health Sciences
      Mapmygenome
      Full Genomes

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Celiac Disease
      Parkinson Disease
      Alzheimer Disease
      Other

      Market Segment by Applications, can be divided into
      Online
      Offline

      Buy now